Dr. Rajanish Manohar Bobde, MD

Dr. Bobde practices at St. John's Riverside Hospital in Yonkers, New York, part of St. John's Riverside Hospital.

Dr. Bobde's NPI, 1932254240, was assigned on January 24, 2007. Dr. Bobde holds New York license 242040.

Dr. Bobde's primary practice is St. John's Riverside Hospital, at 976 North Broadway, Yonkers, NY 10701 in Westchester County. The practice phone is (914) 964-4444. Dr. Bobde also practices at St Johns Riverside Hospital - Andrus Pavillion, 967 N Broadway, Yonkers, NY 10701.

Dr. Bobde's primary practice is St. John's Riverside Hospital in Yonkers, New York, part of St. John's Riverside Hospital. Dr. Bobde is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is Rajanish M Bobde Medical. Dmand AI also links Dr. Bobde to 2 more hospitals, 1 breast imaging center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bobde practices, 6 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Bobde's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Bobde is licensed in New York.

CMS data shows 5,096 Medicare services from Dr. Bobde across 6 procedure codes in 2024, for 653 Medicare patients. Medicare paid $373,183 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 653 Medicare patients who saw Dr. Bobde in 2024. The largest group is 75 to 84, with 229 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 51% are also on Medicaid. Their average risk score is 3.35, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bobde's median patient age at 66, with 49% women.

In 2024, Dr. Bobde wrote 97 Medicare Part D claims for 34 patients. 91% of them were for generic drugs. CMS names the drug for 60 of them, across 3 drugs with 11 or more claims each, at $52,250 in total drug cost. In 2023, CMS named 95 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 48 out of 100 for Dr. Bobde for performance year 2024, reported individually. Dr. Bobde accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Bobde, published from 2018 to 2022. Dr. Bobde's most frequent co-authors are Michael Bekkerman, DO, Rohail Haider, DO and Shireen Jalal Hijaz, MD.

CMS Open Payments shows 181 general payments to Dr. Bobde from 30 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Organogenesis Inc. paid the most, $2,081.